New Drugs: Beta Blockers and Sympathomimetics
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Briant R, Dollery C, Fenyvesi T, George C
. Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol. 1973; 49(1):106-14.
PMC: 1776418.
DOI: 10.1111/j.1476-5381.1973.tb08272.x.
View
2.
Kumana C, Kaye C, Leighton M, Turner P, Hamer J
. Cardiac and pulmonary effects of acebutolol. Lancet. 1975; 2(7925):89-93.
DOI: 10.1016/s0140-6736(75)90001-x.
View
3.
Gibbons D, Lant A, Ashford A, Collins R, Pinder S
. Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline. Br J Clin Pharmacol. 1976; 3(1):177-84.
PMC: 1428816.
DOI: 10.1111/j.1365-2125.1976.tb00586.x.
View
4.
Winkle R, Meffin P, Ricks W, Harrison D
. Acebutolol metabolite plasma concentration during chronic oral therapy. Br J Clin Pharmacol. 1977; 4(5):519-22.
PMC: 1429145.
DOI: 10.1111/j.1365-2125.1977.tb00779.x.
View
5.
Benson M, Berrill W, STERLING G, Decalmer P, Chatterjee S, Croxson R
. Cardioselective and non-cardioselective beta-blockers in reversible obstructive airways disease. Postgrad Med J. 1977; 53 Suppl 3:143-8.
View